Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...
OpenAI is taking on Google DeepMind on its home turf with GPT-Rosalind, a biology-focused AI that outperformed GPT-5.4 on six ...
Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...
Pranam Chatterjee, PhD, assistant professor of bioengineering at the University of Pennsylvania (UPenn), emphasizes that text is all you need for artificial intelligence (AI) models to effectively ...
DAVIS, Calif.--(BUSINESS WIRE)--OpenFold, a non-profit artificial intelligence (AI) research consortium, today announced the release of two new tools: 1) SoloSeq, which integrates a new protein Large ...
Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...
Proteins are the workhorses that keep our cells running, and there are many thousands of types of proteins in our cells, each performing a specialized function. Researchers have long known that the ...
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...
A new artificial intelligence model developed by USC researchers and published in Nature Methods can predict how different proteins may bind to DNA with accuracy across different types of protein, a ...
They build our bodies and orchestrate the molecular processes in cells that keep them healthy. They also present a wealth of targets for new medications. From everyday pain relievers to sophisticated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results